Question 1

What is the catalog number for EHMT2/G9A (EHMT2) Human Knockdown Lysate?

Accepted Answer

The catalog number for EHMT2/G9A (EHMT2) Human Knockdown Lysate is LY300514.

Question 2

What sizes are available for EHMT2/G9A (EHMT2) Human Knockdown Lysate?

Accepted Answer

EHMT2/G9A (EHMT2) Human Knockdown Lysate is available in the following size(s): 100 µg.

Question 3

Is EHMT2/G9A (EHMT2) Human Knockdown Lysate in stock?

Accepted Answer

EHMT2/G9A (EHMT2) Human Knockdown Lysate is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is EHMT2/G9A (EHMT2) Human Knockdown Lysate used for?

Accepted Answer

GenuIn WB-validated EHMT2 Knockdown MCF7 Cell Lysate

Question 5

What temperature does this product ship at?

Accepted Answer

Shipping temperature is chosen based on the product’s stability needs, ranging from ambient to dry ice, and is indicated on the product page. Any related shipping fee is shown clearly in your quotation.

Question 6

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Question 7

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

EHMT2/G9A (EHMT2) Human Knockdown Lysate

Product Specifications

UniProt

Gene Location

Storage Conditions

Symbol

Frequently Asked Questions

Explore Other Products

MASP1 (NM_001879) Human Recombinant Protein

OR7G1 Human Gene Knockout Kit (CRISPR)

Ep-CAM / CD326 (Extracellular Domain) (Epithelial Marker) (EGP40/1798), 0.2mg/mL

NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), CF647 conjugate, 0.1mg/mL

CD73 (Immuno-Oncology Target) (NT5E/2545), 1mg/mL

Tissue Total RNA, Breast